{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:47:10Z","timestamp":1751867230506},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To analyze and explore the evolution and short-term efficacy of neoadjuvant therapy for patients with mid and low LARC in Wuhan Union Hospital Cancer Center.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients diagnosed with rectal cancer from January 2015 to December 2021 were collected. The treatment patterns, short-term efficacy and treatment-related adverse events (AEs) of mid and low LARC patients who received neoadjuvant therapy were analyzed. The Chi-square test was used to compare the differences between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 980 patients with mid and low LARC were enrolled, over time, the proportion of patients receiving neoadjuvant therapy gradually increased, and the treatment mode of direct surgery after diagnosis was gradually watered down. More than 80% of the patients implemented radiotherapy-based neoadjuvant therapy, and the proportion of patients receiving SCRT sequential systemic therapy gradually exceeded that of LCRT combined chemotherapy after 2020. Of all patients who completed radiotherapy and underwent surgery, 170 patients received long-course chemoradiotherapy (LCRT) combined with chemotherapy (Group C) and 98 patients received short-course radiotherapy (SCRT) combined with systemic therapy (chemotherapy with or without immunotherapy) (Group D). The pathological complete response (pCR) rate in Group D was significantly higher than that in Group C (38.8% vs. 19.4%, <jats:italic>P<\/jats:italic>\u2009=\u20090.001). The pCR rate in the SCRT plus immunotherapy group was better than that in the group without immunotherapy (49.2% vs. 21.6%, <jats:italic>P<\/jats:italic>\u2009=\u20090.007). 82.3% of the patients receiving immunotherapy were treated with SCRT sequential 2-cycle CapOX plus Camrelizumab treatment, and the pCR was as high as 52.9%. Immunotherapy did not increase the incidence of Grade 3\u20134 AEs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Neoadjuvant therapy based on radiotherapy is becoming used in patients with mid and low LARC. SCRT sequential systemic therapy is increasingly widely used in LARC patients in our center. Compared with the traditional LCRT or SCRT sequential chemotherapy, SCRT sequential chemotherapy plus immunotherapy has a remarkable pCR rate and manageable toxicity. Looking forward this new treatment mode will bring lasting survival benefits to patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-022-02081-8","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T03:15:37Z","timestamp":1655694937000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center"],"prefix":"10.1186","volume":"17","author":[{"given":"Meng-Lan","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Dan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"issue":"1","key":"2081_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"RS Zheng","year":"2022","unstructured":"Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2016. JNCC. 2022;2(1):1\u20139. https:\/\/doi.org\/10.1016\/j.jncc.2022.02.002.","journal-title":"JNCC"},{"issue":"2","key":"2081_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2009.23.9194","volume":"28","author":"LL Gunderson","year":"2010","unstructured":"Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol. 2010;28(2):256\u201363. https:\/\/doi.org\/10.1200\/JCO.2009.23.9194.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2081_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.6004\/jnccn.2018.0061","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. Rectal cancer, version 2. 2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(7):874\u2013901. https:\/\/doi.org\/10.6004\/jnccn.2018.0061.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"2081_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/s1470-2045(12)70187-0","volume":"13","author":"C R\u00f6del","year":"2012","unstructured":"R\u00f6del C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012;13(7):679\u201387. https:\/\/doi.org\/10.1016\/s1470-2045(12)70187-0.","journal-title":"Lancet Oncol"},{"issue":"8","key":"2081_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","volume":"30","author":"B Cisel","year":"2019","unstructured":"Cisel B, Pietrzak L, Michalski W, Wyrwicz L, Rutkowski A, Kosakowska E, et al. Long-course preoperative chemoradiation versus 5\u2009\u00d7\u20095 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol. 2019;30(8):1298\u2013303. https:\/\/doi.org\/10.1093\/annonc\/mdz186.","journal-title":"Ann Oncol"},{"issue":"1","key":"2081_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342. https:\/\/doi.org\/10.1016\/s1470-2045(20)30555-6.","journal-title":"Lancet Oncol"},{"key":"2081_CR7","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1016\/j.annonc.2020.04.052","volume":"31","author":"S Yuki","year":"2020","unstructured":"Yuki S, Bando H, Tsukada Y, Inamori K, Komatsu Y, Homma S, et al. SO-37 Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stability and microsatellite instability-high, locally advanced rectal cancer (EPOC 1504). Ann Oncol. 2020;31:S230\u20131. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.052.","journal-title":"Ann Oncol"},{"issue":"11","key":"2081_CR8","doi-asserted-by":"publisher","first-page":"e003554","DOI":"10.1136\/jitc-2021-003554","volume":"9","author":"Z Lin","year":"2021","unstructured":"Lin Z, Cai M, Zhang P, Li G, Liu T, Li X, et al. Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer. J Immunother Cancer. 2021;9(11):e003554. https:\/\/doi.org\/10.1136\/jitc-2021-003554.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2081_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/01.pas.0000213312.36306.cc","volume":"31","author":"TT Wu","year":"2007","unstructured":"Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, et al. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol. 2007;31(1):58\u201364. https:\/\/doi.org\/10.1097\/01.pas.0000213312.36306.cc.","journal-title":"Am J Surg Pathol"},{"issue":"9666","key":"2081_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","volume":"373","author":"P Quirke","year":"2009","unstructured":"Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(09)60485-2.","journal-title":"Lancet"},{"key":"2081_CR11","doi-asserted-by":"publisher","unstructured":"Diagnosis, treatment guidelines for colorectal cancer working group C. Chinese society of clinical oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version). Chin J Cancer Res. 2019;31(1):117\u201334. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.01.07.","DOI":"10.21147\/j.issn.1000-9604.2019.01.07"},{"issue":"suppl 15","key":"2081_CR12","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1200\/JCO.2021.39.15_suppl.3510","volume":"39","author":"J Jin","year":"2021","unstructured":"Jin J, Yuan T, Chen H, Yong C, Yuan Z, Guanghui C, et al. A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): the final reports. J Clin Oncol. 2021;39(suppl 15):3510. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.3510.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2081_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12094-016-1522-0","volume":"19","author":"F Alongi","year":"2017","unstructured":"Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, et al. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol. 2017;19(2):189\u201396. https:\/\/doi.org\/10.1007\/s12094-016-1522-0.","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"2081_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s11547-020-01189-9","volume":"125","author":"E Bertocchi","year":"2020","unstructured":"Bertocchi E, Barugola G, Nicosia L, Mazzola R, Ricchetti F, Dell\u2019Abate P, et al. A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study. Radiol Med. 2020;125(10):990\u20138. https:\/\/doi.org\/10.1007\/s11547-020-01189-9.","journal-title":"Radiol Med"},{"issue":"8","key":"2081_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nrclinonc.2016.30","volume":"13","author":"MB Bernstein","year":"2016","unstructured":"Bernstein MB, Krishnan S, Hodge JW, Chang JY. Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? Nat Rev Clin Oncol. 2016;13(8):516\u201324. https:\/\/doi.org\/10.1038\/nrclinonc.2016.30.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2081_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/PPO.0000000000000181","volume":"22","author":"JE Schoenhals","year":"2016","unstructured":"Schoenhals JE, Seyedin SN, Tang C, Cortez MA, Niknam S, Tsouko E, et al. Preclinical rationale and clinical considerations for radiotherapy plus immunotherapy: going beyond local control. Cancer J. 2016;22(2):130\u20137. https:\/\/doi.org\/10.1097\/PPO.0000000000000181.","journal-title":"Cancer J"},{"issue":"4","key":"2081_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","volume":"83","author":"D Schaue","year":"2012","unstructured":"Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys. 2012;83(4):1306\u201310. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.049.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02081-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02081-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02081-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T03:16:03Z","timestamp":1655694963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02081-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2081"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02081-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was in accordance with the ethical standards of the institution and with the Declaration of Helsinki (as revised in 2013) and approved by the ethics committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors agree on publishing the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}